Fengjuan Han
Overview
Explore the profile of Fengjuan Han including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
You W, Wang S, Li C, Ma Y, Liu F, Shen Y, et al.
Int J Gynaecol Obstet
. 2025 Mar;
PMID: 40052494
Endometriosis is a prevalent chronic gynecological disease that poses significant challenges for treatment due to its extensive lesions, diverse morphology, unknown etiology, and tendency for recurrence. In the early 21st...
2.
Zhang A, Huang J, Liu Y, Gong H, Guan F, Li W, et al.
Int J Biol Macromol
. 2024 Nov;
282(Pt 3):137129.
PMID: 39486733
Despite the notable therapeutic effects of bioactive components derived from naturally occurring medicinal plants, various factors such as low solubility, poor bioavailability, possible toxicity, and inadequate tumor targeting capabilities generally...
3.
Chen Q, Li C, Wei W, Li J, Liu F, Fu Y, et al.
Front Oncol
. 2024 Sep;
14:1446552.
PMID: 39319052
The endoplasmic reticulum (ER) is one of the largest organelles, and Endoplasmic Reticulum Stress Response Pathway is a series of responses triggered by the homeostatic imbalance of the ER and...
4.
Wang S, Liu S, Liu F, Guo Y, Han F
Front Oncol
. 2024 Jul;
14:1421828.
PMID: 39015504
Background: The newest clinical evidence that the relationship between the peritoneal cancer index (PCI) and the postoperative prognosis of advanced ovarian cancer patients remains controversial, and there are no large-sample...
5.
Peng C, Wang Y, Guo Y, Li J, Liu F, Fu Y, et al.
J Ethnopharmacol
. 2024 Jun;
334:118491.
PMID: 38936644
Ethnopharmacological Relevance: Cervical cancer (CC) is a potentially lethal disorder that can have serious consequences for a woman's health. Because early symptoms are typically only present in the middle to...
6.
Ding D, Liu S, Liu F, Hao S, Zhang C, Shen Y, et al.
Front Pharmacol
. 2024 Jun;
15:1376037.
PMID: 38910886
Background: Ovarian endometriotic cysts (OEC) represent the primary manifestation of endometriosis, constituting a hormonally dependent inflammatory disorder in gynecology. It significantly affects the quality of life and reproductive health of...
7.
Yu Y, Li S, Sun J, Wang Y, Xie L, Guo Y, et al.
Genes Genomics
. 2024 May;
46(6):689-699.
PMID: 38691326
Background: Ovarian cancer (OC) is the second most commonly seen cancer in the US, and patients with OC are commonly diagnosed in the advanced stage. Research into the molecular mechanisms...
8.
Wang Y, Xie L, Liu F, Ding D, Wei W, Han F
J Ethnopharmacol
. 2023 Oct;
319(Pt 2):117299.
PMID: 37816474
Ethnopharmacological Relevance: As a "silent killer" that threatens women's lives and health, ovarian cancer (OC) has the clinical characteristics of being difficult to detect, difficult to treat, and high recurrence....
9.
Liu F, Xu J, Yang R, Liu S, Hu S, Yan M, et al.
Biomed Pharmacother
. 2022 Dec;
157:114084.
PMID: 36481407
Cervical cancer (CC), as the most common malignant tumor of the female reproductive system, is infamous for its high morbidity and mortality rates. Its development and metastasis are intricate because...
10.
Hu S, Jing Y, Liu F, Han F
Biomed Res Int
. 2022 Aug;
2022:3915402.
PMID: 35978646
Background: Current studies on the relationship between XRCC3 rs861539 polymorphism and ovarian cancer risk have been inconsistent. Therefore, we performed a meta-analysis to explore their association. Methods: Six electronic databases...